Status:
ACTIVE_NOT_RECRUITING
A Study of the Acceptability and Performance of Wearables for Atrial Fibrillation Screening in Older Adults
Lead Sponsor:
University of Cambridge
Collaborating Sponsors:
City, University of London
University of Leicester
Conditions:
Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
65+ years
Brief Summary
\--- Background and study aim Atrial fibrillation (AF) is an irregular heart rhythm which causes a five-fold increase in the risk of stroke. Approximately one in ten people aged over 70 have AF. If A...
Detailed Description
\--- Where is the study run from? The University of Cambridge. \--- Study procedures Participants will be asked to: 1. Consent: Participants will be asked to confirm their consent to take part by ...
Eligibility Criteria
Inclusion
- AF screening successfully completed during the SAFER Programme
- Aged 65 years or over
- Lives in private accommodation
- Willing and able to give informed consent
Exclusion
- Regularly sleeps on front
- Has a chest wound
- Previous reaction to, or known allergy to ECG electrodes or silicone
- Receiving palliative care
Key Trial Info
Start Date :
February 2 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 23 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04715555
Start Date
February 2 2023
End Date
May 23 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cambridge
Cambridge, United Kingdom